Integra LifeSciences Holdings (IART)

Debt-to-equity ratio

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands 1,087,920 1,395,820 1,300,490 1,388,680 1,408,220
Total stockholders’ equity US$ in thousands 1,545,280 1,587,880 1,804,400 1,684,800 1,514,870
Debt-to-equity ratio 0.70 0.88 0.72 0.82 0.93

December 31, 2024 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $1,087,920K ÷ $1,545,280K
= 0.70

The debt-to-equity ratio of Integra LifeSciences Holdings has shown a declining trend over the past five years. Starting at 0.93 as of December 31, 2020, the ratio decreased steadily to 0.70 by December 31, 2024. This indicates that the company has been gradually reducing its reliance on debt in relation to equity in its capital structure. A lower debt-to-equity ratio generally implies a lower financial risk, as it suggests that the company is financing a smaller portion of its operations through debt, which can be a positive sign for investors and creditors. Overall, the decreasing trend in the debt-to-equity ratio of Integra LifeSciences Holdings suggests a strengthening financial position in terms of capital structure management.